Prophylaxis of venous thromboembolism in medical patients

Indication for Dalteparin

Population group: Suitable for both men and women, only adults (18 years old or older)

For this indication, competent medicine agencies globally authorize below treatments:

5,000 IU once daily

Route of admnistration

Subcutaneous

Defined daily dose

5,000 - 5,000 [iU]

Dosage regimen

From 5,000 To 5,000 [iU] once every day

Detailed description

The recommended dose of dalteparin sodium is 5,000 IU once daily. Treatment with dalteparin sodium is prescribed for up to 14 days.

Active ingredient

Dalteparin is an antithrombotic agent, which acts mainly through its ability to potentiate the inhibition of Factor Xa and thrombin by antithrombin. It has a relatively higher ability to potentiate Factor Xa inhibition than to prolong plasma clotting time (APTT).

Read more about Dalteparin

Related medicines

Summary of Product Characteristics (SPC) 2020: FRAGMIN 5.000 IU Solution for injection
Summary of Product Characteristics (SPC) 2020: FRAGMIN 100.000 IU Solution for injection
Summary of Product Characteristics (SPC) 2020: FRAGMIN 10.000 IU Solution for injection
Summary of Product Characteristics (SPC) 2020: FRAGMIN 12.500 IU Solution for injection
Summary of Product Characteristics (SPC) 2020: FRAGMIN 2.500 IU Solution for injection
Summary of Product Characteristics (SPC) 2020: FRAGMIN 7.500 IU Solution for injection

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner